Abstract
Benzene is a well known hematotoxicant which induces hematopoietic dyscrasias of varying intensities in different individuals and even in different strains of the same experimental animal species. Although there is ample evidence that diverse responses to benzene are related to differences in benzene metabolism, we have recently provided evidence implicating differences in host target cell susceptibility to these diverse responses to benzene. The present study extends our previous work and concerns strain-specific differences in marrow progenitor cells that survive benzene exposure. Two mouse strains (Swiss-Webster and C57B1/6J) which respond to benzene exposure with different intensities of bone marrow cytotoxicity were used. Bone marrow cells from benzene-exposed and untreated mice were cultured with one of five benzene metabolites: 1,4-benzoquinone (BQ), catechol (C), hydroquinone (HQ), muconic acid (MA) or phenol (P) and the abilities of these cells to produce erythroid (CFU-e) or granulocyte/macrophage colonies (GM-CFU-c) were assessed. In both strains, marrow cells isolated from benzene-exposed mice showed a higher percentage of plated CFU-e surviving culture with BQ, HQ or MA than marrow cells isolated from control mice. In contrast, both strains of benzene-exposed mice displayed decreased percentages of plated CFU-e surviving culture with catechol than cells isolated from control mice. Only one condition (the culturing of cells with HQ under GM-CFU-c forming conditions) showed any strain-specific difference in plating efficiency. In all, 20 possible combinations of benzene metabolites and cell types were examined (5 metabolites × 2 progenitor cell types × 2 strains). With seven of these combinations, the colony-forming efficiencies were higher for plated cells isolated from benzene-exposed mice than from untreated mice. With three combinations, the colony-forming efficiencies were lower for cells from benzene-exposed mice, and for ten combinations, there were no changes in plating efficiencies. Possible mechanisms for an acquired resistance to the toxicities of benzene metabolites were explored by measuring the concentrations of hepatic and bone marrow sulfhydryl (SH) groups in cells isolated from benzene-exposed and untreated mice. In both strains, benzene exposure induced no changes in hepatic SH concentrations, but the SH content of bone marrow was more than doubled after benzene exposure in both strains. These results suggest that a fraction of hematopoietic progenitor cells are able to survive severe benzene exposure and produce progeny because of a marked increase in marrow SH groups which react with electrophilic benzene metabolites. Moreover, this protective mechanism occurs in two mouse strains with differing susceptibilities to benzene.
Similar content being viewed by others
References
Aksoy M (1988) Benzene carcinogenicity. CRC Press, Boca Raton, Fla.
Aksoy M (1989) Hematotoxicity and carcinogenicity of benzene. Environ Health Perspect 82: 193–197.
ATSDR (1989) Toxicological profile for benzene. ATSDR/TP-88/03
Broxmeyer J (1978) Inhibition in vivo of mouse granulopoiesis by cell free activity derived from human polymorphonuclear neutrophils. Blood 51: 889–901.
Dempster A, Snyder CA (1990) Short term benzene exposure provides a growth advantage for granulopoietic progenitor cells over erythroid progenitor cells. Arch Toxicol 64: 539–544.
Dempster A, Snyder CA (1991) Kinetics of granulocytic and erythroid progenitor cells are affected differently by short-term, low level benzene exposure. Arch Toxicol 65: 556–561.
Dunnett C (1964) New tables for multiple comparisons with a control. Biometrics 20: 483–491.
Green J, Snyder CA, Lobue J, Goldstein BD, Albert R (1981) Acute and chronic dose/response effect of benzene inhalation on the peripheral blood, bone marrow and spleen cells of CD-1 male mice. Toxicol Appl Pharmacol 59: 204–214.
McCleod D, Shreeve M, Axelrad A (1974) Improved plasma culture system for production of erythrocytic colinies in vitro: quantitative assay method for CFU-e. Blood 44: 517–534.
Nakajima T, Wang R, Elovaara E, Gelboin H, Vainio, H (1993) Cytochrome P450-related differences between rats and mice in the metabolism of benzene, toluene and trichloroethylene in liver microsomes. Biochem Pharmacol 45[5]: 1079–1085.
Neun D, Penn A, Snyder CA (1992) Evidence for strain-specific differences in benzene toxicity as a function of host target cell susceptibility. Arch Toxicol 66: 11–17.
Rushmore T, Snyder R, Kalf G (1984) Covalent binding of benzene and its metabolities to DNA in rabbit mitochondria in vitro. Chem Biol Interact 49: 133–154.
Sawahata T, Neal R (1983) Biotransformation of phenol to hydroquinone and catechol by rat liver microsomes. Mol Pharmacol 23: 453–460.
Sedlak J, Lindsay, R (1968) Estimation of total, protein-bound and non-protein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem 25: 192–205.
Sheridan J, Metcalf D (1973) A low molecular weight factor in lungconditioned medium stimulating granulocyte and monocyte formation in vitro. J Cell Physiol 81: 11–24.
Smart R, Zannoni V (1984) DT-diaphorase and peroxidase influence the covalent binding of the metabolites of phenol, the major metabolite of benzene. Mol Pharmacol 26[1]: 105–111.
Snyder CA (1987) Benzene. In: Snyder R (ed) Ethel Browning’s toxicity and metabolism of industrial solvents, 2nd ed., Vol. I Hydrocarbons. Elsevier, New York, pp 3–37
Snyder CA, Glodstein BD, Sellakumar A, Wolman S, Bromberg I, Ehrlichman M, Laskin S (1978) Hematotoxicity of inhaled benzene to Sprague-Dawley rats and AKR mice at 300 ppm. J Toxicol Environ Health 4: 605–618.
Snyder CA, Goldstein BD, Sellakumar A, Bromberg I, Laskin S, Albert R (1980) The inhalation toxicology of benzene: incidence of hematopoietic neoplasms and hematotoxicity in AKR/J and C57Bl/6J mice. Toxicol Appl Pharmacol 54: 323–331.
Snyder CA, Goldstein BD, Sellakumar A, Bromberg I, Laskin S, Albert R (1982) Toxicity of chronic benzene inhalation: CD-1 mice exposed to 300 ppm. Bull Environ Contam Toxicol 29: 385–391
Snyder R, Chepiga T, Yang C, Thomas H, Platt K, Oesch F (1993) Benzene metabolism by reconstituted cytochromes P450 2B1 and 2E1 and its modulation by cytochrome b5, microsomal hydrolase and glutathione transferases: evidence for an important role of microsomal epoxide hydrolase in the formation of hydroquinone. Toxicol Appl Pharmacol 122[2]: 172–181
Subrahmanyam V, Sadler A, Suba E, Ross D (1989) Stimulation of in vitro bioactivation of hydroquinone by phenol in bone marrow cells. Drug Metab Dispos 17: 348–350.
Tunek A, Platt K, Przybylski M, Oesch F (1980) Multi-step metabolic activation of benzene. Effect of superoxide dismutase on covalent binding to microsomal macromolecules and identification of glutathione conjugates using high pressure liquid chromatography and field desorption mass spectrometry. Chem Biol Interact 33: 1–7
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Neun, D.J., Penn, A. & Snyder, C.A. Erythroid progenitor cells that survive benzene exposure exhibit greater resistance to the toxic benzene metabolites benzoquinone and hydroquinone. Arch Toxicol 68, 535–540 (1994). https://doi.org/10.1007/s002040050110
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s002040050110